TrialCancer research and treatment2023

Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 Study.

Jongheon Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.